Join the Luvox group to help and get support from people like you.
Luvox News
Fluvoxamine Does Not Shorten Duration of COVID-19 Symptoms
TUESDAY, Nov. 28, 2023 – Fluvoxamine does not reduce duration of COVID-19 symptoms in patients with mild or moderate COVID-19, according to a study published online Nov. 17 in the Journal of the ...
Study Debunks Notion That Antidepressant, Fluvoxamine, Might Ease COVID Symptoms
MONDAY, Sept. 18, 2023 – A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
Including Celexa (citalopram); Lexapro (escitalopram); Prozac, Sarafem, Symbyax (fluoxetine); Luvox, Luvox CR (fluvoxamine); Paxil, Paxil CR, Pexeva (paroxetine); Zoloft (sertraline); Viibryd...
FDA Medwatch Alert: Antidepressant Medication Products
[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitors (SSRIs) - Serotonin Syndrome
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...
FDA Medwatch Alert: SSRIs and Treatment Challenges of Depression in Pregnancy
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women...
FDA Medwatch Alert: Fluvoxamine
[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject...
FDA Medwatch Alert: Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults
The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening...
FDA Medwatch Alert: Public Health Advisory - Suicidality in Pediatric Patients Treated with Antidepressants for Major Depressive Disorder
The FDA notified healthcare professionals of reports of the occurrence of suicidality (both suicidal ideation and suicide attempts) in clinical trials for various antidepressant drugs in pediatric...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Anxiety and Stress, Obsessive Compulsive Disorder